| Name | Title | Contact Details |
|---|
The Argen Corporation is the world`s largest manufacturer of precious dental gold alloys, leader in zirconia manufacturing, and leading innovator of digital dentistry solutions and scrap refining services. With more than 50 years serving the dental industry, Argen now distributes to more than 100 countries with subsidiaries in Canada, China, Germany and the United Kingdom. Argen enables dental labs of all sizes to integrate digital into every aspect of their workflow by offering a wide range of digitally-produced products and services. Argen is proud to be a family-owned American company that manufactures the highest quality products in the US and is dedicated to treating customers like family.
Dentek Inc is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Molecular Biometrics is a Chester, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AliveCor, Inc. is pioneering the creation of FDA-cleared machine learning techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared KardiaMobile is the most clinically validated mobile EKG solution on the market. It is recommended by leading cardiologists and used by people worldwide for accurate EKG recordings. KardiaMobile, and KardiaBand, when paired with the Kardia app provide instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an EKG. Kardia is the first A.I. enabled platform to help clinicians manage patients for the early detection of atrial fibrillation, the most common cardiac arrhythmia and one that leads to a five times greater risk of stroke. KardiaBand is the first FDA-cleared medical device accessory for Apple Watch. AliveCor is recognized by FastCompany as 2018`s No. 1 most innovative company in artificial intelligence. AliveCor is a privately-held venture backed company headquartered in Mountain View, Calif.
In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.